Bacopa Monnieri

Last updated: May 4, 2025

Also Known As:

["bacopa"]

Bacopa Monnieri, also known as Brahmi, is a traditional medicinal plant from Ayurveda used for centuries, primarily found in wet, tropical environments. It works by interacting with brain systems involved in memory and stress, and is most known for enhancing cognitive functions like memory recall and reducing anxiety. Studies consistently show Bacopa improves memory performance, particularly free recall, after several weeks of use, and it also demonstrates significant neuroprotective and anti-anxiety effects.

Categories & Effectiveness
Dosage & Side Effects
Benefits by Use Case
Mechanism of Action
Frequently Asked Questions
Summary & Expert Opinion
Research Studies

Back to All Nootropics

Categories & Effectiveness

Cognition

Neuroprotection & Plasticity

7/10

Strong evidence of effectiveness

Working & Long-term Memory

7/10

Strong evidence of effectiveness

Attention & Focus

4/10

Moderate evidence of effectiveness

Mood

Anxiety / Stress Reduction

7/10

Strong evidence of effectiveness

Relaxation / Sleep Preparation

4/10

Moderate evidence of effectiveness

Dosage & Side Effects

Recommended Dosage

The commonly recommended dosage for Bacopa Monnieri extract in adults ranges from 300 mg to 450 mg per day, often standardized to a specific percentage of bacosides (e.g., 30-55%). Studies suggest benefits emerge with consistent daily use over several weeks, typically around 12 weeks, with lower doses like 250mg (125mg twice daily) also showing efficacy in some populations like those with age-associated memory impairment. While generally safe within these ranges, exceeding recommended doses isn't associated with greater benefits and may increase side effect risk; always start lower to assess tolerance.

Potential Side Effects

Common mild side effects are infrequent but may include gastrointestinal upset like diarrhoea or nausea, and occasionally mild headache, though these were sometimes reported in placebo groups as well. Severe side effects are rare, but one study noted a single case of maculopapular rashes where the link to Bacopa was uncertain; overall safety profiles in clinical trials appear favorable. Individuals with existing gastrointestinal sensitivity might be more prone to mild digestive issues; otherwise, Bacopa is generally well-tolerated based on available research.

Interactions & Stacks

Bacopa Monnieri is often used alone due to its broad cognitive benefits, but users sometimes stack it with other nootropics targeting different pathways, like L-Theanine for added relaxation or Citicoline for cholinergic support. Caution is advised when combining Bacopa with medications affecting the cholinergic system due to its potential modulation of acetylcholine; consult a healthcare provider before combining it with other supplements or medications. User reports and preliminary research suggest its effects are most pronounced with consistent, long-term use rather than acute stacking strategies.

Benefits by Use Case

Memory Enhancement

Improves memory free recall and logical memory significantly with consistent use over weeks. Effects are cumulative and may take 8-12 weeks to become fully apparent.

Anxiety Reduction

Reduces symptoms of anxiety and lowers stress markers like cortisol levels after several weeks of supplementation. It is not typically used for acute anxiety relief.

Cognitive Boost for Aging

Helps mitigate age-associated memory impairment (AAMI) by improving mental control, memory, and learning. Benefits observed in older adults without dementia after 12 weeks.

Focus & Concentration

Enhances aspects of cognitive processing including concentration, alertness, and mental flexibility. Some acute effects on concentration seen, but sustained benefits require chronic use.

Mechanism of Action

Bacopa Monnieri exerts its nootropic effects through multiple pathways, primarily involving its active compounds, bacosides. These compounds modulate key neurotransmitter systems, particularly the cholinergic system, by influencing acetylcholine release, choline acetylase activity, and potentially muscarinic receptor binding, which are crucial for learning and memory. Additionally, Bacopa possesses potent antioxidant properties, protecting brain cells from oxidative stress, a factor in cognitive decline and neurodegenerative diseases. Research also indicates it can increase levels of brain-derived neurotrophic factor (BDNF), a protein vital for neuron growth, survival, and synaptic plasticity, further supporting cognitive function and neuroprotection.

Frequently Asked Questions

Is Bacopa Monnieri safe?

When should I take Bacopa?

How long does it take for Bacopa to work?

Can Bacopa help with Alzheimer's?

Does Bacopa improve all types of memory?

Can I take Bacopa for stress?

Will Bacopa help me sleep better?

Summary & Expert Opinion

Overall, Bacopa Monnieri stands out as a well-researched nootropic with consistent evidence supporting its benefits for memory enhancement, anxiety reduction, and neuroprotection. Its primary strengths lie in improving memory recall and reducing stress markers with chronic use, backed by multiple randomized controlled trials showing good safety and tolerability. However, its effects require patience, typically taking 8-12 weeks to manifest, and evidence for enhancing cognitive domains beyond memory (like reasoning or language) is less robust or consistent across studies. Healthy adults seeking gradual improvements in memory, learning, and stress resilience, as well as older individuals experiencing age-related memory changes, are likely candidates for Bacopa. Those seeking immediate cognitive boosts or who are taking cholinergic medications should explore other options or consult a healthcare provider before use.

Research Studies

Showing 5 of 9 studies

Bacopa Monnieri (2024)

cognition memory memory free recall

Findings:

This systematic review found some evidence suggesting Bacopa monnieri improves memory free recall (improved performance on 9/17 tests across 6 studies). Evidence for enhancement in other cognitive abilities was lacking, potentially due to inconsistent measurement methods across studies.

Participants:

Adult humans without dementia or significant cognitive impairment.

Dosage:

300-450 mg extract per day (across three different Bacopa extracts used in the reviewed trials).

Study Quality Assessment:

Systematic review of randomized, controlled human clinical trials (N=6). Trials were assessed for methodological quality. All trials had a duration of 12 weeks. Limitations noted: inconsistent measures used across studies for cognitive domains other than memory; paucity of research in domains like reasoning, number facility, language behavior; research is in its infancy.

Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study (2024)

anxiety reduction cognitive function concentration +2 more

Authors:

Harshith Chandra Shekhar, Jestin V Thomas, Lincy Joshua, Mohan Muttanahally Eraiah

Findings:

Bacopa monnieri extract (BME) supplementation significantly improved multiple domains of memory (verbal short-term, spatial short-term, working, visuospatial working, episodic) and cognitive skills (concentration, alertness, reasoning, mental flexibility) compared to placebo over 12 weeks, with effects emerging from Day 14-28. BME also significantly reduced anxiety (BAI scores) and serum cortisol, improved sleep quality (PSQI scores), and increased serum BDNF levels compared to placebo. An acute significant effect on concentration was observed 3 hours post single dose, however, no significant effects were found for sustained attention or planning tasks; BME was found safe and well-tolerated.

Participants:

Eighty healthy male and female adults aged 18-55 years (N=80 randomized, 74 completed) with normal cognition profile (MMSE score ~24).

Dosage:

300 mg of Bacopa monnieri extract (BME), containing 90 mg of total bacosides (standardized to 30%), taken as one capsule every morning after breakfast for 12 weeks (84 days).

Study Quality Assessment:

Randomized, double-blind, placebo-controlled, parallel group study (N=80). Assessments included Creyos battery of tests, Beck Anxiety Inventory (BAI), Pittsburgh Sleep Quality Index (PSQI), serum BDNF, serum cortisol, safety monitoring (physical examination, vital signs, clinical laboratory tests, adverse events). Approved by Institutional Ethics Committee and conducted per ICMR guidelines, ICH-GCP (E6R2), and Declaration of Helsinki. Registered with Clinical Trials Registry of India (CTRI/2023/05/052880). Sample size calculation and statistical methods described. Funding source disclosed (Samriddh Nutractive Private Limited); Conflict of Interest declared as None.

All Effects:

anxiety reduction cognitive function concentration memory sleep quality

Bacopa monnieri (2023)

cognitive enhancement memory memory free recall

Authors:

Eric A. Walker, Mark V. Pellegrini

Findings:

This systematic review found some evidence that Bacopa monnieri improves memory free recall, based on results from 6 randomized controlled trials. Across studies, Bacopa improved performance on 9 of 17 memory free recall tests. There was little evidence of enhancement in other cognitive domains, potentially due to inconsistent measures used.

Participants:

Adult humans without dementia or significant cognitive impairment (subjects from the reviewed trials).

Dosage:

300-450 mg extract per day (using three different Bacopa extracts across studies).

Study Quality Assessment:

Systematic review of randomized, controlled human clinical trials (N=6 included studies). Trials were objectively assessed for methodological quality. All included trials were conducted over 12 weeks. Limitation noted: inconsistent measures employed by studies across cognitive domains other than memory.

Neuropharmacological Review of the Nootropic Herb Bacopa monnieri (2013)

Alzheimer's Disease clinical trials needed neuroprotection

Authors:

Sebastian Aguiar, Thomas Borowski

Findings:

The text identifies Alzheimer's disease (AD) as a progressive neurodegenerative disease of the elderly and states that further research, specifically clinical trials in humans, is necessary to prove the usefulness of Bacopa monnieri in treating AD.

Study Quality Assessment:

Mentions the need for 'clinical trials in humans'.

Bacopa monnieri

Chronic effects of Brahmi (Bacopa monnieri) on human memory

memory

Neuroprotection with Bacopa monnieri-A review of experimental evidence

Alzheimer's disease epilepsy neurological disorders +2 more

Findings:

This review collates literature demonstrating the neuroprotective potential of Bacopa monnieri (Brahmi) in several neurological and psychiatric disorders, including Alzheimer's disease, epilepsy, Parkinson's disease, Huntington's disease, cerebral ischemia/infarct, and neoplasms.

Study Quality Assessment:

Review methodology: English language articles from databases PubMed, Scopus and Google scholar searched (as of May 2020) using keywords and MeSH terms.

All Effects:

Alzheimer's disease epilepsy neurological disorders neuroprotection psychiatric disorders

Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture

anti-anxiety anti-cancer antioxidant +3 more

Findings:

This review summarizes evidence suggesting *Bacopa monnieri* extracts (BME) possess neuroprotective properties (e.g., against beta-amyloid, oxidative stress), potentially benefiting conditions like Alzheimer's and Parkinson's disease, and enhancing cognitive functions. Clinical trials cited indicate improvements in memory, learning, attention, cognitive processing, and mood, particularly with chronic use. The review also discusses BME's potential anti-cancer activities (inhibiting cell growth/migration, inducing apoptosis) and protective effects against various toxins.

Participants:

The review covers studies involving various *in vitro* cell lines (e.g., primary cortical neurons, PC12, SH-SY5Y, IMR32, U-87 MG), *in vivo* animal models (e.g., mice, rats, C. elegans, Drosophila), and human clinical trials with participants including healthy adults (various age ranges, N=17 to N=107), elderly individuals (N=12, N=60, N=98), children/adolescents (N=100), medical students (N=60), and patients with specific conditions like anhedonia (N=19) or dementia (N=12). Toxicity studies involved mice, rats, Drosophila, and C. elegans.

Dosage:

Dosages vary widely across cited studies. Clinical trials commonly used 300mg/day (for 12 weeks or 90 days), 320mg/day (12 weeks), or 150mg twice daily (6 weeks). Other reported clinical doses include 160mg/day or 320mg/day (16 weeks, children based on weight), 250mg twice daily (3 months), 300mg twice daily (4 weeks), 450mg/day (>90kg individuals), and acute doses of 320mg or 640mg. Preclinical doses range from μg/mL or μM concentrations in vitro (e.g., 50μM Bacoside A, 80-100 μg/mL BME) to mg/kg body weight in animal models (e.g., 40-300 mg/kg).

Study Quality Assessment:

The review cites multiple clinical studies described as 'randomized', 'double-blind', and/or 'placebo-controlled' with specified sample sizes (N=17 to N=107). It also mentions a 'pilot study' (N=12). Preclinical studies utilized specific cell lines, animal models, and methods (e.g., Morris Water Maze, AChE assays, RT-PCR, immunofluorescence). Toxicity assessments included acute and chronic oral toxicity testing in rats. The review acknowledges funding sources (NMPB, Ministry of AYUSH, ICMR-DHR, CSIR, DST) and is published in the peer-reviewed journal 'Frontiers in Nutrition'.

All Effects:

anti-anxiety anti-cancer antioxidant cognitive enhancement memory neuroprotection

We value your privacy

Categories & Effectiveness

Cognition

Neuroprotection & Plasticity

Working & Long-term Memory

Attention & Focus

Mood

Anxiety / Stress Reduction

Relaxation / Sleep Preparation

Dosage & Side Effects

Recommended Dosage

Potential Side Effects

Interactions & Stacks

Benefits by Use Case

Memory Enhancement

Anxiety Reduction

Cognitive Boost for Aging

Focus & Concentration

Mechanism of Action

Frequently Asked Questions

Summary & Expert Opinion

Research Studies

Bacopa Monnieri (2024)

Findings:

Participants:

Dosage:

Study Quality Assessment:

Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study (2024)

Authors:

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Bacopa monnieri (2023)

Authors:

Findings:

Participants:

Dosage:

Study Quality Assessment:

Neuropharmacological Review of the Nootropic Herb Bacopa monnieri (2013)

Authors:

Findings:

Study Quality Assessment:

Bacopa monnieri

Chronic effects of Brahmi (Bacopa monnieri) on human memory

Findings:

Participants:

Neuroprotection with Bacopa monnieri-A review of experimental evidence

Findings:

Study Quality Assessment:

All Effects:

Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment

Authors:

Similar Nootropics

L-Theanine

Phosphatidylserine

Aniracetam

Ashwagandha